help information
46.4 ° F
Full Weather

Adamis 3Q Earnings Snapshot

SAN DIEGO _ Adamis Pharmaceuticals Corp. (ADMP) on Friday reported a loss of $8.9 million in its third quarter.

On a per-share basis, the San Diego-based company said it had a loss of 21 cents.

The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of 15 cents per share.

The biopharmaceutical company posted revenue of $3.8 million in the period, which also fell short of Street forecasts. Three analysts surveyed by Zacks expected $5.4 million.

In the final minutes of trading on Friday, the company’s shares hit $2.78. A year ago, they were trading at $4.70.


This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on ADMP at https://www.zacks.com/ap/ADMP